NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Survivorship

Preventing Chronic Breast Cancer-Related Lymphedema: Practical Insights for Operationalizing a Lymphedema Surveillance Program

Featured Faculty
Dr. Steven Chen, Chief Medical Officer, ImpediMed
Dr. Allison DiPasquale, Breast Surgeon and Breast Oncology Director, Medical City Dallas
Dr. Manpreet Kohli, Breast Program Director, Monmouth Medical Center



Join our experts! Dr. Steven Chen, Chief Medical Officer, will be joined by Dr. Allison DiPasquale and Dr. Manpreet Kohli to discuss the importance of early detection and intervention for Breast Cancer-Related Lymphedema (BCRL) and provide their insights into operationalizing a Lymphedema Surveillance Program. Hear their expert perspectives on the role of bioimpedance spectroscopy (BIS) technology as well as the latest clinical practice guideline and research updates.

Learning Objectives

  • Early Detection & Intervention for Subclinical Lymphedema: Why It’s Important for our Patients
  • Clinical Guideline & PREVENT Trial Analysis Updates: Evidence-Based Insights Supporting Early Detection of Lymphedema
  • Operationalizing a Lymphedema Surveillance Program: Best Practices for Implementation & Patient Compliance


Featured Faculty

Dr. Steven Chen - Chief Medical Officer, ImpediMed

Dr. Steven Chen

Chief Medical Officer, ImpediMed

Dr. Chen currently serves as ImpediMed’s Chief Medical Officer. Most recently, Dr. Chen was the Chief Medical Officer for Avelas Biosciences. He has also served as the Chief of Breast Surgery at UC Davis Medical Center, followed by a position as an Associate Professor of Surgery and as the associate program director of the surgical oncology training program at City of Hope National Medical Center in Duarte, California. Dr. Chen is a past President of the American Society of Breast Surgeons. Dr. Chen serves on committees for a number of professional societies including the American Medical Association, the Society of Surgical Oncology, and the American College of Surgeons. He is also a practicing surgeon in San Diego, California, and the Director of Surgical Oncology at OasisMD

Dr. Allison DiPasquale - Breast Surgeon, US Oncology

Dr. Allison DiPasquale

Breast Surgeon and Breast Oncology Director, Medical City Dallas

Dr. DiPasquale is dedicated to the treatment and cure of breast cancer. Her commitment is personal having experienced her own family members being affected by the disease. As a result, she sought fellowship training to specialize in breast surgical oncology and practices oncoplastic reconstruction of the breast to leave both the patient and the breast with minimal reminders of cancer. Dr. DiPasquale’s research interests include triple negative breast cancer, intraoperative radiation, and leading-edge techniques to improve the appearance of the breast after surgery. She serves as the President, Board of Directors of Susan G Komen Dallas and is the Director of Breast Oncology at Medical City Dallas as well as participates on advisory boards to help improve breast cancer care.

Dr. Manpreet Kohli - Breast Surgeon & Breast Program Director, Monmouth Medical Center

Dr. Manpreet Kohli

Breast Surgeon & Breast Program Director, Monmouth Medical Center

Manpreet K. Kohli, MD, FACS is the Director of Breast Surgery for Monmouth Medical Center, affiliated with Rutgers Cancer Institute of New Jersey and RWJBarnabas Health. Dr. Kohli is a Cancer Liaison Physician for the Commission on Cancer. She strives to provide the highest level of comprehensive and compassionate care to set patients up for a long and successful survivorship utilizing the latest advancements in the field of breast surgery. Her professional memberships include, The American Society of Breast Surgeons, Society of Surgical Oncology, Association of Women Surgeons, and American Society of Clinical Oncology.

SOZO Device with L-Dex

Learn More About SOZO®

SOZO uses ImpediMed’s BIS technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. SOZO is non-invasive, fast, and easy to use. Results from the 30-second test* are available immediately providing proactive patient care including early detection of disease progression, treatment monitoring, and patient education.

*As tested on Android

Contact Us